APA (7th ed.) Citation

J, E., M, M., EK, H., C, B., F, J., S, M., . . . FR, B. (2021). The potent and selective RIPK2 inhibitor BI 706039 improves intestinal inflammation in the TRUC mouse model of inflammatory bowel disease. American journal of physiology. Gastrointestinal and liver physiology, 321(5), G500. https://doi.org/10.1152/ajpgi.00163.2021

Chicago Style (17th ed.) Citation

J, Ermann, et al. "The Potent and Selective RIPK2 Inhibitor BI 706039 Improves Intestinal Inflammation in the TRUC Mouse Model of Inflammatory Bowel Disease." American Journal of Physiology. Gastrointestinal and Liver Physiology 321, no. 5 (2021): G500. https://doi.org/10.1152/ajpgi.00163.2021.

MLA (9th ed.) Citation

J, Ermann, et al. "The Potent and Selective RIPK2 Inhibitor BI 706039 Improves Intestinal Inflammation in the TRUC Mouse Model of Inflammatory Bowel Disease." American Journal of Physiology. Gastrointestinal and Liver Physiology, vol. 321, no. 5, 2021, p. G500, https://doi.org/10.1152/ajpgi.00163.2021.